Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:05 PM
Ignite Modification Date:
2025-12-24 @ 2:05 PM
NCT ID:
NCT06238895
Eligibility Criteria:
Inclusion Criteria:
* Informed Consent signed by the subject
* ≥18 years of age
* Iron deficiency: Ferritin \<30 µg/l
* hemoglobin ≥ 80 g/l
* CRP \< 5 mg/l
Exclusion Criteria:
* Refusal of study participation,
* Regular administration of Erythropoietin
* Oral or intravenous iron supplementation \<12 weeks prior to investigation
* Contraindications to intervention medication (Tardyferon), e.g. known hypersensitivity or allergy to iron sulfate / ferrous sulfate
* Blood transfusion or donation \<12 weeks prior to investigation
* Active chemotherapy
* Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, dementia, etc. of the subject.
Note
Due to slow recruitment, the following inclusion criterion was removed on 09/25/2024 (MM/DD/YYYY):
Anemia (as defined by the WHO): Hemoglobin \<130 g/L for men, Hemoglobin \<120 g/l for women, Hemoglobin \<110 g/l for pregnant women
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06238895
Study Brief:
Protocol Section:
NCT06238895